eucalyptol has been researched along with Diabetic Glomerulosclerosis in 2 studies
Excerpt | Relevance | Reference |
---|---|---|
"Eucalyptol is a natural constituent in aromatic plants with antioxidant properties." | 1.48 | Eucalyptol Inhibits Advanced Glycation End Products-Induced Disruption of Podocyte Slit Junctions by Suppressing Rage-Erk-C-Myc Signaling Pathway. ( Kang, MK; Kang, YH; Kim, DY; Kim, YH; Lee, EJ; Oh, H, 2018) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kim, DY | 2 |
Kang, MK | 2 |
Kim, YH | 2 |
Lee, EJ | 2 |
Oh, H | 2 |
Kim, SI | 1 |
Oh, SY | 1 |
Kang, YH | 2 |
2 other studies available for eucalyptol and Diabetic Glomerulosclerosis
Article | Year |
---|---|
Eucalyptol Ameliorates Dysfunction of Actin Cytoskeleton Formation and Focal Adhesion Assembly in Glucose-Loaded Podocytes and Diabetic Kidney.
Topics: Actin Cytoskeleton; Animals; Cells, Cultured; Diabetic Nephropathies; Eucalyptol; Focal Adhesions; G | 2019 |
Eucalyptol Inhibits Advanced Glycation End Products-Induced Disruption of Podocyte Slit Junctions by Suppressing Rage-Erk-C-Myc Signaling Pathway.
Topics: Animals; Cell Line; Diabetic Nephropathies; Eucalyptol; Glucose; Glycation End Products, Advanced; I | 2018 |